Heparan sulfate-binding growth factor (null)

Heparan sulfate-binding growth factors are not a single molecule but refer to a diverse group of **soluble proteins** that possess domains enabling them to bind heparan sulfate glycosaminoglycan chains on cell surface or matrix proteoglycans[2][7]. This interaction regulates numerous biological processes—including cell proliferation, differentiation, angiogenesis, morphogenesis, and immune modulation—by serving as a co-receptor system that modulates signal transduction, ligand bioavailability, and spatial distribution[1][2][6]. Notable members of this group include the **fibroblast growth factor (FGF) family**, **vascular endothelial growth factors (VEGF)**, some **Wnt proteins**, and others involved in morphogenesis and inflammation[7][5][6]. The functionality and specificity of these interactions depend on the sulfation patterns along the heparan sulfate chains[7][9]. Dysregulation of heparan sulfate interactions with growth factors is associated with cancer, cardiovascular disease, developmental disorders, and altered tissue repair[5][6][8]. Importantly, "Heparan sulfate-binding growth factor" describes a molecular interaction or property, not a canonical, singular drug target. For structured pharmacological databases, these growth factors must be specified individually (e.g., "Fibroblast growth factor 2").

Other names

Heparin-binding growth factorHBGFHS-binding growth factor

Many drugs and molecules act by modulating the interaction between heparan sulfate proteoglycans and their applicable growth factors[2][6]. Drugs or mimetics may block the growth factor-HS interaction, enhance binding, or alter downstream signaling. Heparin analogs or competitive inhibitors can disrupt growth factor activity and signal transduction[6].